Clinical assessment of gepotidacin (GSK2140944) as a victim and perpetrator of drug-drug interactions via CYP3A metabolism and transportersCTS-CLINICAL AND TRANSLATIONAL SCIENCEIF2.82023-01-236OA
Inhaled glucocorticoid-induced metabolome changes in asthmaEUROPEAN JOURNAL OF ENDOCRINOLOGYIF5.22022-09-0110OAAI
Inhaled corticosteroid (ICS) induced metabolome changes in asthmaticsEUROPEAN RESPIRATORY JOURNALIF212020-10-281PRE
Therapeutic index of inhaled corticosteroids in asthma: A dose-response comparison on airway hyperresponsiveness and adrenal axis suppressionBRITISH JOURNAL OF CLINICAL PHARMACOLOGYIF32020-06-1742OAAI
Late Breaking Abstract - Dose responses for topical efficacy and systemic activity, dose equivalence and relative therapeutic index for fluticasone furoate (FF), fluticasone propionate (FP) and budesonide (BUD) in asthmatic subjectsEUROPEAN RESPIRATORY JOURNALIF212019-11-213PRE
Dopaminergic drug treatment remediates exaggerated cingulate prediction error responses in obsessive-compulsive disorderPSYCHOPHARMACOLOGYIF3.32019-06-1432OAAI
Investigation of the Brain Biodistribution of the Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) Inhibitor [18F]GSK2647544 in Healthy Male SubjectsMOLECULAR IMAGING AND BIOLOGYIF2.52016-07-1112OAAI
Response Perseveration in Stimulant Dependence Is Associated with Striatal Dysfunction and Can Be Ameliorated by a D2/3 Receptor AgonistBIOLOGICAL PSYCHIATRYIF92011-10-01110PREAI